BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MLSC
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220623T120000
DTEND;TZID=America/New_York:20220623T130000
DTSTAMP:20260407T120714
CREATED:20220622T132824Z
LAST-MODIFIED:20220622T132824Z
UID:16676-1655985600-1655989200@www.masslifesciences.com
SUMMARY:The Secret Sauce: Tips & Tricks for a Successful BLUE KNIGHT™ QuickFire Challenge: Next-Generation Preparedness Solutions Application
DESCRIPTION:Join us for an Information Session about the BLUE KNIGHT™ QuickFire Challenge. Ahead of the submission deadline approaching on July 22nd\, attendees will have an opportunity to: \n• Learn more about the Challenge’s key focus areas related to infectious disease\, immunology\, & the microbiome (more details below)\n• Get the inside scoop on what makes an applicant stand out\n• Learn the do’s and don’ts for submissions\n• Ask questions to experts from Johnson & Johnson Innovation and BARDA \nAbout the Challenge: \nNew infectious diseases have been emerging with increased frequency\, furthering the likelihood of another pandemic or serious health threat occurring during our lifetime – potentially as soon as within the next decade.1 In today’s interconnected world\, there is a greater need to work together to spark potential solutions for tomorrow’s known and unknown public health threats. New innovations\, particularly those with multi-use potential\, are needed to help rapidly and efficiently respond to emerging health security threats and infectious diseases. \nBLUE KNIGHT™\, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA)\, part of the Office of the Assistant Secretary for Preparedness Response (ASPR) at the U.S. Department of Health and Human Services (HHS)\, seeks to answer this call by anticipating potential health security threats\, activating the global innovation community\, and amplifying scientific and technological advancements. That’s why Johnson & Johnson Innovation\, together with BARDA\, launched the BLUE KNIGHT™ QuickFire Challenge: Next-Generation Preparedness Solutions Application. \nInnovators developing potentially ground-breaking ideas or technologies that aim to enhance preparedness solutions towards future known and unknown infectious disease threats are invited to submit ideas for up to $200\,000 in total award funding and access to the global Johnson & Johnson Innovation – JLABS network through Blue Knight residency with mentorship from experts at the Johnson & Johnson Family of Companies and BARDA. Innovators must be developing potential preparedness solutions addressing at least one of the following QuickFire Challenge focus areas: \n-Targeting the host response to known and unknown future infectious disease threats\n-Enabling streamlined manufacturing of therapeutics and/or vaccines\n-Leveraging the host microbiome
URL:https://www.masslifesciences.com/event/the-secret-sauce-tips-tricks-for-a-successful-blue-knight-quickfire-challenge-next-generation-preparedness-solutions-application/
LOCATION:Virtual Event
ORGANIZER;CN="Johnson & Johnson Innovation":MAILTO:clee22@its.jnj.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220624T080000
DTEND;TZID=America/New_York:20220624T160000
DTSTAMP:20260407T120714
CREATED:20220527T192609Z
LAST-MODIFIED:20220527T192609Z
UID:16581-1656057600-1656086400@www.masslifesciences.com
SUMMARY:USA-India Chamber of Commerce 16th annual BioPharma & Healthcare Summit
DESCRIPTION:USAIC’s annual BioPharma & Healthcare Summit is a top industry event for senior executives focused on Drug Discovery & Development\, Partnering\, Licensing\, External Research\, Translational Research\, Clinical Trails\, Data & Digital Sciences\, Medical Devices\, Healthcare\, Innovation and Emerging Markets. \nThe virtual event will be chaired by Andrew Plump\, President of R&D\, Takeda Pharmaceuticals\, and will feature talks from speakers such as Alex Gorsky\, Executive Chairman\, Johnson & Johnson and Lawrence Tabak\, Acting Director\, NIH. Topics will include R&D strategies and trends\, digital & data science in healthcare and more. \nRegistration is complimentary\, though seats are limited. Register online!
URL:https://www.masslifesciences.com/event/usa-india-chamber-of-commerce-16th-annual-biopharma-healthcare-summit/
LOCATION:Virtual Event
ORGANIZER;CN="USA-India Chamber of Commerce":MAILTO:https://usaindiachamber.org/index.php
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220628T084500
DTEND;TZID=America/New_York:20220628T160000
DTSTAMP:20260407T120714
CREATED:20220608T221410Z
LAST-MODIFIED:20220608T221410Z
UID:16625-1656405900-1656432000@www.masslifesciences.com
SUMMARY:Free Symposia: Unlocking High-Throughput Biology
DESCRIPTION:Please join Carterra at our upcoming symposium in Boston\, MA. You will spend the day learning about high-throughput drug discovery and antibody therapeutics with some of the industry’s leading scientists. Our speakers will present new ways of looking at discovery\, applications\, and workflows\, including HT-SPR. The topics you’ll hear about include: \n– Antibody discovery in 90 days! Screening\, identification & characterization\n– New methods in DELs\, PROTACs and other formats\n– New technology and innovations during the pandemic\n– Data analysis routines & automation\n– Best practices in analyzing SPR data \nNetwork with your peers. Lunch will be provided. Registration is required as seating is limited.
URL:https://www.masslifesciences.com/event/free-symposia-unlocking-high-throughput-biology/
LOCATION:Le Meridien Cambridge\, 20 Sidney Street\, Cambridge\, MA
ORGANIZER;CN="Carterra":MAILTO:questions@carterra-bio.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220629T090000
DTEND;TZID=America/New_York:20220629T110000
DTSTAMP:20260407T120714
CREATED:20220623T160948Z
LAST-MODIFIED:20220623T160948Z
UID:16727-1656493200-1656500400@www.masslifesciences.com
SUMMARY:MassEcon Spotlight Series: Greater Boston Region Spotlight
DESCRIPTION:As MassEcon focuses on marketing Massachusetts beyond its borders\, we invite you to this Spotlight Series discussion. Join us for: \n\n\nHigh-level snapshot of industry trends in the area\nInteractive Roundtable Discussion: Why Greater Boston works as a business location\n\n\nAgenda: \n\n8:30 am: Registration\n9 am: Welcome and Introductions\n9:10 am: An Economic Overview of Greater Boston: Trends\, Advantages\, Competition\n9:45 am: Moderated Panel Discussion: What are the competitive Advantages of the Greater Boston region as a location for businesses\n10:30 am: Audience Q&A\n10:55 am: Wrap-up Remarks\n11:00 am: Event Close
URL:https://www.masslifesciences.com/event/massecon-spotlight-series-greater-boston-region-spotlight/
LOCATION:MassBio\, 700 Technology Square 5th Floor\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220629T160000
DTEND;TZID=America/New_York:20220629T190000
DTSTAMP:20260407T120714
CREATED:20220608T221523Z
LAST-MODIFIED:20220608T221523Z
UID:16621-1656518400-1656529200@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-9/
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220707T160000
DTEND;TZID=America/New_York:20220707T180000
DTSTAMP:20260407T120714
CREATED:20220624T171832Z
LAST-MODIFIED:20220624T171832Z
UID:16729-1657209600-1657216800@www.masslifesciences.com
SUMMARY:Career Pathways in Biotech
DESCRIPTION:Join us for networking and hear from a panel of professionals across the industry to uncover the career possibilities that exist in biotech \nAbout this event: \nLabCentral Ignite is pleased to welcome a diverse group of interns who are spending their summer working in the Boston-Cambridge biotech industry. \nAttendees will hear from a panel of professionals who will share their journeys into biotech\, the experiences that got them there\, and a little about their day-to-day work. There will also be opportunities for networking and discussion. Refreshments will be served and we encourage interns to invite their supervisors to join\, as well! \nPanelists include: \nTendai Chisowa\, Hummingbird VC \nMichelle Lira\, New England Biolabs \nSusannah Calhoun\, Parthenon Therapeutics \nJuan Patarroyo\, LabCentral \nUzo Erlingsson\, LEAS Lab \nNote: We will follow LabCentral’s COVID-19 safety protocols that are in place at the time of the event. Masks will likely be required for this event.
URL:https://www.masslifesciences.com/event/career-pathways-in-biotech/
LOCATION:LabCentral 238\, 238 Main Street 6th Floor\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220720T160000
DTEND;TZID=America/New_York:20220720T200000
DTSTAMP:20260407T120714
CREATED:20220627T160453Z
LAST-MODIFIED:20220627T160453Z
UID:16697-1658332800-1658347200@www.masslifesciences.com
SUMMARY:M2D2 IMPACT Cycle 3 Accelerator Pitch-Off
DESCRIPTION:Hear ten medical device startups selected for the IMPACT Accelerator Program pitch their innovation to a panel of industry experts. \nJoin Massachusetts life sciences community as the startups from the Cycle 3 Cohort pitch their medical device solution to a panel of judges. These startups are working with M2D2 and Hologic to advance the commercialization of their innovation through the IMPACT Accelerator Program.
URL:https://www.masslifesciences.com/event/m2d2-impact-cycle-3-accelerator-pitch-off/
LOCATION:110 Canal St\, 110 Canal St\, Lowell\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220721T090000
DTEND;TZID=America/New_York:20220721T190000
DTSTAMP:20260407T120714
CREATED:20220630T171958Z
LAST-MODIFIED:20220630T171958Z
UID:16754-1658394000-1658430000@www.masslifesciences.com
SUMMARY:MALSI DAY 2022
DESCRIPTION:Now in its 15th year\, Massachusetts Life Sciences Innovation (MALSI) Day brings scientific leaders\, post-docs\, professors\, entrepreneurs\, innovators\, and venture capitalists to celebrate the most important day for life sciences startups and innovation in the Commonwealth of Massachusetts. \nThis year’s exciting program and speakers will showcase Creating the New Normal: Life In The Fast Lane. The agenda includes keynote presentations\, panel discussions\, an emerging technology poster competition\, an innovators’ marketplace\, networking opportunities with leading life sciences CEOs\, and more! \nMALSI is presented by Innovation Studio in partnership with MassVentures\, and all the major organizations involved in starting and supporting the life sciences startup ecosystem in the Commonwealth.
URL:https://www.masslifesciences.com/event/malsi-day-2022/
LOCATION:District Hall Boston\, 75 Northern Avenue\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Innovation Studio":MAILTO:press@innovationstudio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220725T120000
DTEND;TZID=America/New_York:20220725T130000
DTSTAMP:20260407T120714
CREATED:20220722T191732Z
LAST-MODIFIED:20220722T191732Z
UID:16862-1658750400-1658754000@www.masslifesciences.com
SUMMARY:Women Leadership in Biotech Summer Webinar Series
DESCRIPTION:In this four-part webinar series\, women leaders will speak about their career journeys and offer advice around the challenges and opportunities in navigating a biotech career. This free webinar series is designed primarily for women leaders at all levels\, but all are welcome. \nThe 2022  topics include: \n\nAddressing Imposter Syndrome in Biotech Leadership and How to Mitigate it\nThe Founder’s Journey: A Guide to Starting a Biotech\n\nJuly 25\, 2022  | 12:00 – 1:00 pm ET\nTwo extraordinary biotech founders Dr Pamela Contag and Dr Jo Viney\, together with moderator Dr Anna Frostegård\, share their journeys building biotech companies\, from initial inception\, investment\, development through to IPO. They will discuss key aspects of building a biotech\, challenges\, and what they wish they had known before embarking on their founders journey.\n\n\nNow that You Have a Seat on the Board\, What to Expect and How to Influence\n\nAugust 3\, 2022  | 12:00 – 1:00 pm ET\nThe board of directors play an essential role in assessing the overall direction and strategy of a business. In this webinar we address what to expect and how to influence as a board member. More specifically:  \n\nHow to break in once you’re on the board?\nHow you operate once you’re on the board\nKey pieces of advice\nHow do you ensure that you pave the way for future women on the board\nAddressing DEI\n\n\n\n\nHow to be Proactive as a Networker\n\nAugust 17\, 2022  | 12:00 – 1:00 pm ET\nWe all know that networking is essential in building a community\, ideas and actions. Networking can at times require a strategic and creative approach. It can also require planning and most certainly stepping outside one’s comfort zone. In this webinar\, our group of experienced biotech executives share best practices on how to be a more effective networker and how to maximize networking opportunities. In addition\, we also address: \n\nHow to evaluate women networking groups\nA look at traditional male networking\nHow to seek out people who can amplify your opportunity to build your personal brand and network\nCase examples
URL:https://www.masslifesciences.com/event/women-leadership-in-biotech-summer-webinar-series/2022-07-25/
LOCATION:Online\, online
ORGANIZER;CN="Conference Forum":MAILTO:service@tcfllc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220727T160000
DTEND;TZID=America/New_York:20220727T190000
DTSTAMP:20260407T120714
CREATED:20220721T144028Z
LAST-MODIFIED:20220721T144028Z
UID:16839-1658937600-1658948400@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-10/
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220825T100000
DTEND;TZID=America/New_York:20220825T120000
DTSTAMP:20260407T120714
CREATED:20220822T210221Z
LAST-MODIFIED:20220822T210221Z
UID:17059-1661421600-1661428800@www.masslifesciences.com
SUMMARY:Engineering strategies for improving adoptive T cell therapy against cancer
DESCRIPTION:The adoptive cell transfer (ACT) of tumor-specific T cells has emerged as a potent treatment against some advanced cancers. For example\, ACT of ex vivo expanded tumor-infiltrating lymphocytes (TILs) has achieved durable and complete responses in about 20% of melanoma patients receiving a single transfusion. In addition\, TCR-redirected T cells targeting the cancer testis antigen NY-ESO-1157-165 have shown important clinical promise against melanoma\, myeloma\, and synovial sarcoma. Furthermore\, ACT with peripheral blood T cells gene-modified to express chimeric antigen receptor (CAR) T cells targeting the B-cell lineage antigen CD19 has led to complete remission for up to 90% of some advanced\, treatment-refractory hematological cancer patients. \nHowever\, unprecedented responses to CAR therapy have not been achieved against epithelial-derived solid tumors\, the most common category of cancers. Indeed\, solid tumors present a variety of barriers to CAR therapy\, including that there is a lack of tumor antigens not also found on healthy tissues\, thus running the risk of on-target but off-tumor toxicity. Hence\, both TCR- and CAR T cells face various immunosuppressive barriers in the solid tumor microenvironment (TME)\, which can be detrimental to their persistence and function. \nCreative Biolabs has invited Dr. Melita Irving to join us in this webinar section and discuss the latest findings of her research team on an innovative CAR design\, hoping to provide insights into the engineering strategies for improving the efficacy and safety of CAR and TCR cell therapies against cancer. \nDuring this webinar\, the following topics will be discussed: \nThe use of syngeneic tumor models to evaluate the ability of co-engineered murine CAR T cells to reprogram the TME and boost T cell function\nThe use of low doses of irradiation to inflame cold tumors and render them responsive to rational combinatorial immunotherapy\nThe novel STOP-CAR integrates efficacy and safety directly into CAR design
URL:https://www.masslifesciences.com/event/engineering-strategies-for-improving-adoptive-t-cell-therapy-against-cancer/
LOCATION:Virtual
ORGANIZER;CN="Creative Biolabs":MAILTO:marketing@creative-biolabs.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220829T090000
DTEND;TZID=America/New_York:20220830T220000
DTSTAMP:20260407T120714
CREATED:20220804T125625Z
LAST-MODIFIED:20220804T125625Z
UID:16927-1661763600-1661896800@www.masslifesciences.com
SUMMARY:Nucleate Summit 2022
DESCRIPTION:The Nucleate Summit will be hosted in Boston\, Massachusetts on August 29-30. \nThe two-day celebration will unify Nucleate’s worldwide community in person for the first time\, connecting hundreds of volunteers\, founders\, and investors. \nThe Leadership Summit (Day 1) includes shared experiences that will strengthen bonds among Nucleate leadership\, alumni\, special guests\, and sponsors. It will also invite participants to explore the city of Boston and its advanced biotech ecosystem. Here\, the action will be off-stage: attendees will form deep connections with biotech leaders and Nucleate’s partners. \nThe Community Summit (Day 2) includes premier networking opportunities\, inspirational speakers\, and the Activator Pitch Showcase\, features recent winners from the 9 Nucleate regions. Many other teams from the Activator 2022 cohort will also attend; they are building on $9 million in funding raised in just the past few weeks.
URL:https://www.masslifesciences.com/event/nucleate-summit-2022/
LOCATION:Royale\, 279 Tremont St\, Boston\, 02116\, United States
ORGANIZER;CN="Nucleate":MAILTO:contact@nucleate.xyz
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220831T160000
DTEND;TZID=America/New_York:20220831T190000
DTSTAMP:20260407T120714
CREATED:20220816T174559Z
LAST-MODIFIED:20220816T174559Z
UID:17043-1661961600-1661972400@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-11/
LOCATION:Virtual
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T131347Z
LAST-MODIFIED:20220711T131347Z
UID:16792-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Pharmacology – Essentials
DESCRIPTION:HMX Pro Pharmacology – Essentials covers the basic concepts required to understand the field of pharmacology today\, with an emphasis on the principles that describe what the body does to a drug and in turn what a drug does to the body.
URL:https://www.masslifesciences.com/event/pharmacology-essentials/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T131427Z
LAST-MODIFIED:20220711T131427Z
UID:16791-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Drug Discovery and Development
DESCRIPTION:With all the advances in science and with closer collaboration between different scientific disciplines\, a multifaceted approach is now being applied to drug discovery and development. Therefore\, learning about the process of drug discovery and development has important implications for anyone working in health care and related sectors. \nThis advanced course offers a unique way for professionals to learn from leading Harvard Medical School faculty about how drugs are developed and about the advances happening in this field that are ultimately helping to improve the treatment and prevention of disease.
URL:https://www.masslifesciences.com/event/drug-discovery-and-development/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T131503Z
LAST-MODIFIED:20220711T131503Z
UID:16790-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Drug Delivery
DESCRIPTION:The range of systems and approaches that can be used to deliver therapeutics is growing and advancing at an incredible rate\, so learning about the advances in drug delivery has important implications for anyone working in health care and related sectors. \nThis online course offers a unique way for professionals to learn from leading Harvard Medical School faculty about cutting-edge drug delivery systems and approaches that can be used in the treatment and prevention of disease.
URL:https://www.masslifesciences.com/event/drug-delivery/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T131559Z
LAST-MODIFIED:20220711T131559Z
UID:16789-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Vaccines and Viral Immunology
DESCRIPTION:Viral infections are responsible for many human diseases\, from common diseases like the flu to emerging infections such as Zika virus and SARS-CoV-2. \nUnderstanding how the immune system works to prevent and remove viral infections is essential for anyone working to develop or distribute vaccines that can protect against these diseases. \nThis advanced course offers a unique way for professionals to learn from leading Harvard Medical School faculty about cutting-edge developments in the creation of vaccines to protect against viral infections.
URL:https://www.masslifesciences.com/event/vaccines-and-viral-immunology/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T131632Z
LAST-MODIFIED:20220711T131632Z
UID:16788-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Novel Therapies for Chronic Inflammation\, Autoimmunity\, and Allergy
DESCRIPTION:Advances in our knowledge of the immune system are uncovering connections between inflammation and many different diseases. \nUnderstanding how the immune system is activated and regulated is essential for anyone working to develop treatments for autoimmunity\, chronic inflammation\, and allergy\, or to apply these treatments in the clinic. \nThis online course offers a unique way for professionals to learn from leading Harvard Medical School faculty about cutting-edge therapies to treat chronic inflammation and related diseases.
URL:https://www.masslifesciences.com/event/novel-therapies-for-chronic-inflammation-autoimmunity-and-allergy/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T131700Z
LAST-MODIFIED:20220711T131700Z
UID:16786-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Genetics – Essentials
DESCRIPTION:The way we diagnose and treat diseases is changing\, with new technologies enabled by a deeper understanding of the human genome and its relationship to health and disease. This shift has broad implications for those who work in health care and related areas. \nHMX Pro Genetics – Essentials covers the basic concepts required to understand the field of genetics today\, with an emphasis on explaining how variation in DNA sequence occurs\, is inherited\, and can lead to disease.
URL:https://www.masslifesciences.com/event/genetics-essentials/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T131743Z
LAST-MODIFIED:20220711T131743Z
UID:16787-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Immuno-oncology
DESCRIPTION:Advances in our knowledge of the immune system are changing the ways in which we treat various types of cancer. \nUnderstanding how immune cells recognize and kill cancer cells\, and what we can do to enhance their ability to fight cancer\, is important for anyone working to develop new cancer treatments or apply them in the clinic. \nThis advanced course offers a unique way for professionals to learn about cutting-edge cancer immunotherapies from leading Harvard Medical School faculty.
URL:https://www.masslifesciences.com/event/immuno-oncology/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T132127Z
LAST-MODIFIED:20220711T132127Z
UID:16784-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Genetic Testing and Sequencing Technologies
DESCRIPTION:The field of genetic testing is expanding and evolving at an incredible rate\, thanks to our growing knowledge of genetic conditions\, dropping costs\, and higher demand. \nThis rapid expansion has dramatically changed how we diagnose and screen for genetic conditions\, who we test\, and how informative the results are. Learning about the recent advances in genetic testing and sequencing technologies has important implications for anyone working in health care and related sectors. \nThis course offers a unique way for professionals to learn about genetic testing and its applications from leading Harvard Medical School faculty.
URL:https://www.masslifesciences.com/event/genetic-testing-and-sequencing-technologies/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T132158Z
LAST-MODIFIED:20220711T132158Z
UID:16783-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Cancer Genomics and Precision Oncology
DESCRIPTION:Growing knowledge of human genetics is changing the way physicians and researchers approach diagnosis of cancer risk as well as treatment of various types of cancer. \nAnyone whose work intersects with cancer needs to understand the vital role that genetic information has begun to play in the field of oncology. \nThis advanced course offers a unique way for professionals to learn about key cancer genetics concepts and cutting-edge clinical applications from leading Harvard Medical School faculty.
URL:https://www.masslifesciences.com/event/cancer-genomics-and-precision-oncology/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T132227Z
LAST-MODIFIED:20220711T132227Z
UID:16782-1662422400-1668815999@www.masslifesciences.com
SUMMARY:HMX Fundamentals - Pharmacology
DESCRIPTION:Understanding how drugs act in the body is vital for effectively treating patients. \nIn HMX Fundamentals Pharmacology\, you’ll learn about the principles governing what the body does to a drug and in turn what a drug does to the body. Along the way you will see how this knowledge comes into play in real-world scenarios and clinical settings.
URL:https://www.masslifesciences.com/event/hmx-fundamentals-pharmacology/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T132305Z
LAST-MODIFIED:20220711T132305Z
UID:16780-1662422400-1668815999@www.masslifesciences.com
SUMMARY:HMX Fundamentals - Genetics
DESCRIPTION:The way we diagnose and treat diseases is changing\, with new technologies enabled by a deeper understanding of the human genome and its relationship to health and disease. \nIn HMX Fundamentals Genetics\, you’ll get an overview of key concepts behind the evolving fields of human genetics\, genomics\, and precision medicine.
URL:https://www.masslifesciences.com/event/hmx-fundamentals-genetics/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T132332Z
LAST-MODIFIED:20220711T132332Z
UID:16779-1662422400-1668815999@www.masslifesciences.com
SUMMARY:HMX Fundamentals - Immunology
DESCRIPTION:Microbial life forms are an ever-present\, extremely dangerous threat to our survival\, against which the immune system must constantly defend. \nIn HMX Fundamentals Immunology\, you’ll learn about the processes that enable our immune systems to respond to evolving threats and learn about new\, immunology-based disease treatments.
URL:https://www.masslifesciences.com/event/hmx-fundamentals-immunology/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T132404Z
LAST-MODIFIED:20220711T132404Z
UID:16778-1662422400-1668815999@www.masslifesciences.com
SUMMARY:HMX Fundamentals - Physiology
DESCRIPTION:Understanding how the body works is vital for effectively treating patients. \nIn HMX Fundamentals Physiology\, you’ll learn essential principles underlying how the human body functions\, and see how this knowledge comes into play in real-world scenarios and in clinical settings from the intensive care unit to the cardiac catheterization lab.
URL:https://www.masslifesciences.com/event/hmx-fundamentals-physiology/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220711T141804Z
LAST-MODIFIED:20220711T141804Z
UID:16781-1662422400-1668815999@www.masslifesciences.com
SUMMARY:HMX Fundamentals - Biochemistry
DESCRIPTION:Understanding biochemistry is an excellent foundation for learning all of biology\, but it can be difficult to make sense of the complexity of biochemical systems. \nIn HMX Fundamentals Biochemistry\, you’ll learn about the principles governing the interactions of individual molecules\, and how those same principles apply at the scale of cells and organisms. Along the way\, you’ll see how biochemistry intersects with human disease and clinical care.
URL:https://www.masslifesciences.com/event/hmx-fundamentals-biochemistry/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260407T120714
CREATED:20220712T131750Z
LAST-MODIFIED:20220712T131750Z
UID:16785-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Gene Therapy
DESCRIPTION:With all the advances in science and with closer collaboration between different scientific disciplines\, gene therapy has become a promising treatment option for some genetic conditions and is being heavily investigated for many others. Therefore\, learning about gene therapy and how it’s done has important implications for anyone working in health care and related sectors. \nThis advanced course offers a unique way for professionals to learn from leading Harvard Medical School faculty about gene therapy and about the advances happening in this field that are ultimately helping to improve the treatment of certain genetic diseases.
URL:https://www.masslifesciences.com/event/gene-therapy/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220912
DTEND;VALUE=DATE:20220913
DTSTAMP:20260407T120714
CREATED:20220725T174748Z
LAST-MODIFIED:20220725T174748Z
UID:16871-1662940800-1663027199@www.masslifesciences.com
SUMMARY:9th Annual Mobile Tech in Clinical Trials
DESCRIPTION:This conference helps R&D operation executives support more patients remotely and to understand where these technologies will and won’t work to ensure full patient support while managing invaluable data collection. \nThe 9th annual event presents the largest number pharma and biotech participation to date who report on mobile and digital implementation strategies and demonstrate the impact of those initiatives.
URL:https://www.masslifesciences.com/event/9th-annual-mobile-tech-in-clinical-trials/
LOCATION:The Westin Copley Place Boston Hotel\, 10 Huntington Ave Boston Massachusetts 2116 United States of\, 10 Huntington Ave\, Boston\, MA\, 2116\, United States
ORGANIZER;CN="Conference Forum":MAILTO:service@tcfllc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220912
DTEND;VALUE=DATE:20220913
DTSTAMP:20260407T120714
CREATED:20220802T134640Z
LAST-MODIFIED:20220802T134640Z
UID:16916-1662940800-1663027199@www.masslifesciences.com
SUMMARY:Clinical Research as a Care Option
DESCRIPTION:Embedding clinical research in the care setting can lead to higher rates of clinical trial participation inside of a health system\, better health outcomes\, lower cost of care and more satisfied patients. CRAACO® is a unique opportunity for pharma\, healthcare and patients to come together and address how we can build a more integrated research ready platform to improve patient access to clinical trials.
URL:https://www.masslifesciences.com/event/clinical-research-as-a-care-option/
LOCATION:The Westin Copley Place Boston Hotel\, 10 Huntington Ave Boston Massachusetts 2116 United States of\, 10 Huntington Ave\, Boston\, MA\, 2116\, United States
ORGANIZER;CN="Conference Forum":MAILTO:service@tcfllc.org
END:VEVENT
END:VCALENDAR